Embecta (EMBC) Cash from Financing Activities (2020 - 2026)

Embecta (EMBC) reported Cash from Financing Activities of -$41.5 million for Q1 2026, down 11.26% on a YoY basis from -$46.8 million in Q1 2025, and up 19.57% sequentially from -$51.6 million in Q4 2025.

Embecta (EMBC) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Embecta (EMBC) has 7 years of Cash from Financing Activities data on file, last reported at -$41.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 11.26% year-over-year to -$41.5 million; the trailing twelve-month figure through Mar 2026 stood at -$237.3 million (down 81.7% YoY), and the FY2025 full-year result was -$226.7 million, down 208.86% from the prior year.
  • Cash from Financing Activities grew to -$41.5 million in Q1 2026, from -$51.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $90.3 million in Q1 2022 to a low of -$81.6 million in Q3 2025.
  • A 5-year average of -$20.9 million and a median of -$13.5 million in 2023 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities soared 179.63% in 2022 and slumped 469.7% in 2023, its largest moves.
  • Tracing EMBC's Cash from Financing Activities over 5 years: stood at -$6.1 million in 2022, then sank by 121.31% to -$13.5 million in 2023, then tumbled by 234.81% to -$45.2 million in 2024, then slipped by 14.16% to -$51.6 million in 2025, then advanced by 19.57% to -$41.5 million in 2026.
  • Business Quant data shows EMBC's Cash from Financing Activities at -$41.5 million in Q1 2026, -$51.6 million in Q4 2025, and -$81.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -133.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -287.90 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -414.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -13.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -255.24 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -164.80 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -75.80 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -50.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -48.13 Mn
10 Embecta 192.72 Mn -678,250.00 127.80 Mn -41.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -41.50 Mn
Mar 31, 2026 -41.50 Mn
Dec 31, 2025 -51.60 Mn
Dec 31, 2025 -51.60 Mn
Sep 30, 2025 -81.60 Mn
Sep 30, 2025 -81.60 Mn
Jun 30, 2025 -62.60 Mn
Jun 30, 2025 -62.60 Mn
Mar 31, 2025 -37.30 Mn
Mar 31, 2025 -37.30 Mn
Dec 31, 2024 -45.20 Mn
Dec 31, 2024 -45.20 Mn
Sep 30, 2024 -36.60 Mn
Sep 30, 2024 -36.60 Mn
Jun 30, 2024 -11.50 Mn
Jun 30, 2024 -11.50 Mn
Mar 31, 2024 -11.80 Mn
Mar 31, 2024 -11.80 Mn
Dec 31, 2023 -13.50 Mn
Dec 31, 2023 -13.50 Mn